Sunday, November 15, 2026

Peer-Reviewed Clinical Evidence Platform

The research that matters, without the jargon.

Peer-reviewed breakthroughs in plain English alongside verified outcomes, evidence grades, and clinical study details for everyone from everyday readers to medical students.

ClearMed Editorial Digest500 briefings across 12 specialties121 Phase III & clinical practice

Indexed from PubMed, NEJM, The Lancet, JAMA, Nature MedicineSaved Library

Health Hubs:

Stage: Evidence:

Showing 64 briefings

Reset all filters

Cardiology

Cardiology Clinical Briefings

Peer-Reviewed Clinical Digests · Verified Scientific Media

CARDIOLOGY · CLINICAL PRACTICE

Dietary Protein Source Linked to Testosterone Levels in Men

For men, the source of dietary protein—animal (especially dairy) versus plant—appears to correlate with significant differences in circulating testosterone levels, suggesting a potential modifiable lifestyle factor. Currently, dietary interventions specifically differentiating between animal and plant protein for modulating testosterone levels are not a standard component of clinical practice beyond general healthy eating guidelines.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 13, 2026

Cardiology editorial photograph for Energy Drinks and Stimulant Supplements Linked to Dramatically Increased Cardiac Arrest and Myocardial Infarction Reports

CARDIOLOGY · CLINICAL PRACTICE

Energy Drinks and Stimulant Supplements Linked to Dramatically Increased Cardiac Arrest and Myocardial Infarction Reports

Energy drinks and stimulant supplements are strongly associated with a significantly increased risk of cardiac arrest and heart attacks, particularly in young adults, necessitating clinical vigilance and patient counseling. The findings from this study are critically important because energy drinks and stimulant supplements largely operate outside the stringent regulatory frameworks applied to pharmaceuticals.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · REAL-WORLD COHORT

Daily Avocado & Mango: New Heart Health Allies?

Daily intake of avocado and mango may positively impact blood vessel health and diastolic blood pressure, offering a simple dietary intervention for cardiovascular well-being. This research suggests a simple, nutrient-rich dietary adjustment could offer a straightforward way to support cardiovascular health, especially for at-risk populations like those with prediabetes.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · REAL-WORLD COHORT

Daily Tea Habit Linked to Lower Heart Disease Risk: The 6-8 Cup Sweet Spot

Consistent daily tea drinking, especially 6-8 cups of black tea, was associated with an 11% lower risk of heart and blood vessel diseases in a large cohort. This research suggests a potentially accessible, dietary intervention that could contribute to cardiovascular health, offering a non-pharmacological avenue for consideration.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · CLINICAL PRACTICE

AI Identifies Hidden Heart Signal for Sudden Death Risk

AI can uncover subtle cardiac risks in routine scans, improving sudden death prediction. This discovery could enable earlier identification of thousands at risk for sudden cardiac death, allowing for timely interventions.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 15, 2026

CARDIOLOGY · CLINICAL PRACTICE

Senior Statins: Short-Term Safety, Long-Term Questions

While stopping statins after 70 might initially seem safe for those without prior heart events, the long-term risks suggest a careful discussion with your doctor is essential. For years, the medical community has debated the optimal duration of statin therapy, especially as patients enter advanced age.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 13, 2026

CARDIOLOGY · PHASE III

Coronary Artery Calcium Scoring Challenges Traditional Statin Prescription Guidelines

Coronary Artery Calcium (CAC) guided statin initiation resulted in similar major cardiovascular event rates with fewer prescriptions and significantly improved patient adherence compared to traditional risk assessments. Current standard of care for primary prevention statin initiation heavily relies on calculated risk scores (e.g., ASCVD risk in the US), which estimate the 10-year risk of atherosclerotic cardiovascular disease events based on factors like age, sex, race, cholesterol levels, blood pressure, and diabetes status.

5/5 Gold Standard

Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · PHASE III

Coronary Artery Calcium Scoring: A New Paradigm for Statin Allocation and Adherence?

Using coronary artery calcium (CAC) scoring to guide statin initiation reduces statin prescriptions without compromising major cardiovascular event prevention, while significantly improving medication adherence. Current guidelines from bodies like the ACC/AHA primarily utilize traditional risk assessment tools, such as the Pooled Cohort Equations, to identify individuals at intermediate to high risk for atherosclerotic cardiovascular disease (ASCVD) who would benefit from statin therapy.

5/5 Gold Standard

Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · REAL-WORLD COHORT

Full-Fat Dairy: Reassessing Decades of Dietary Advice

Full-fat dairy may not be the metabolic villain once thought, prompting a review of dietary advice. These findings suggest current dietary guidelines regarding dairy consumption may need re-evaluation, potentially impacting patient counseling.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · REAL-WORLD COHORT

Gene Editing: Lifelong Promise, Long-Term Safety Question

While gene editing offers the potential for lifelong disease prevention, its permanent effects demand rigorous, extended safety validation before widespread clinical use. If successful, this could significantly improve patient adherence and outcomes for chronic conditions by eliminating the need for daily medication.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · GUIDELINE / OPINION

Hypertension Guidelines Rethink: Potassium Intake Joins Sodium Reduction

Effective blood pressure management should consider both reducing sodium and actively increasing potassium intake for optimal results. This updated perspective could significantly influence future clinical guidelines for hypertension, moving towards a more balanced dietary approach.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

CARDIOLOGY · PRECLINICAL

Hidden Pathway in Cholesterol Regulation Identified, Novel Drug Shows Promise

A newly identified cholesterol regulation pathway and a drug in early development targeting it hold promise for future high LDL-C treatments. This discovery offers a novel therapeutic target for managing high cholesterol, potentially benefiting patients whose LDL levels are not adequately controlled by current treatments.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDailyNov 12, 2026

Showing 12 of 64 medical briefings

Interactive Fact Check